表紙
市場調查報告書

美國的血栓消除設備市場:技術,類型,疾病,實用性別的機會分析與產業預測

U.S. Thrombectomy Devices Market by Technology, Type, Disease, and Utility: Opportunity Analysis and Industry Forecast, 2018 - 2025

出版商 Allied Market Research 商品編碼 807205
出版日期 內容資訊 英文 119 Pages
商品交期: 2-3個工作天內
價格
Back to Top
美國的血栓消除設備市場:技術,類型,疾病,實用性別的機會分析與產業預測 U.S. Thrombectomy Devices Market by Technology, Type, Disease, and Utility: Opportunity Analysis and Industry Forecast, 2018 - 2025
出版日期: 2019年02月19日內容資訊: 英文 119 Pages
簡介

本報告提供美國的血栓消除設備市場的相關調查,提供市場機會,投資,策略,成長及阻礙因素,各技術·類型·疾病·實用性·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
  • 相關利益者的主要優點
  • 主要市場區隔
    • 本報告所調查的主要企業清單
  • 調查方法
    • 二次調查
    • 一次調查
    • 分析工具及模式

第2章 摘要整理

  • 研究主要的調查結果
  • CXO的觀點

第3章 市場概況

  • 市場定義及範圍
  • 主要調查結果
    • 主要的勝利策略
    • 主要的投資品牌
  • 主要企業的地位 2017年
  • 波特的五力分析
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會

第4章 美國的血栓消除設備市場:各技術

  • 概要
    • 市場規模及預測
  • 機械血栓切除裝置
  • 吸入血栓切除裝置
  • 溶血性血栓切除裝置

第5章 美國的血栓消除設備市場:各類型

  • 概要
    • 市場規模及預測
  • 自動
  • 手動

第6章 美國的血栓消除設備市場:各疾病

  • 概要
    • 市場規模及預測
  • 神經血管血栓除去裝置
  • 週邊血栓除去裝置
  • 冠狀動脈血栓除去裝置

第7章 美國的血栓消除設備市場:實用性別

  • 概要
    • 市場規模及預測
  • 可重複使用
  • 拋棄式

第8章 企業簡介

  • BOSTON SCIENTIFIC CORPORATION
  • JOHNSON & JOHNSON
  • MEDTRONIC PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • KONINKLIJKE PHILIPS N.V.
  • Angiodynamics Inc
  • Penumbra, Inc.
  • Capture Vascular, Inc.
目錄
Product Code: LI_195195

Title:
U.S. Thrombectomy Devices Market by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025.

U.S. Thrombectomy Devices Market Overview:

Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts-brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.

The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.

The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.

Key Benefits for U.S. Thrombectomy Devices Market:

The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.

The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.

The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018-2025.

Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.

U.S. Thrombectomy Devices Key Market Segments:

By Technology

  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices

By Type

  • Automated Thrombectomy Devices
  • Manual Thrombectomy Devices

By Disease

  • Peripheral Thrombectomy Devices
  • Coronary Thrombectomy Devices
  • Neural Thrombectomy Devices

By Utility

  • Reusable Thrombectomy Devices
  • Disposable Thrombectomy Devices
  • Key Market Players
  • Boston Scientific Corporation
  • Medtronic plc
  • Teleflex Incorporated
  • Penumbra, Inc.
  • Koninklijke Philips N.V.
  • AngioDynamics, Inc.
  • Terumo Corporation
  • Johnson and Johnson
  • Stryker Corporation
  • Capture Vascular, Inc.
  • The other players in the value chain include (profiles not included in the report)
  • Argon Medical Devices, Inc.
  • Inari Medical, Inc.

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
    • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top winning strategies
    • 3.2.2. Top investment pockets
  • 3.3. Top player positioning, 2017
  • 3.4. Porters five forces analysis
  • 3.5. Market dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
      • 3.5.1.2. Surge in demand for minimally invasive procedures
      • 3.5.1.3. Technological advancements & innovations
    • 3.5.2. Restraints
      • 3.5.2.1. High cost and complications associated with the use of thrombectomy devices
      • 3.5.2.2. Dearth of trained professionals & lack of awareness
    • 3.5.3. Opportunities
      • 3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
      • 3.5.3.2. Combination of decompressive surgery and thrombectomy

CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Mechanical thrombectomy devices
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast
  • 4.3. Aspiration thrombectomy devices
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast
  • 4.4. Rheolytic thrombectomy devices
    • 4.4.1. Key market trends, growth factors, and opportunities
    • 4.4.2. Market size and forecast

CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Automated thrombectomy devices
    • 5.2.1. Market size and forecast
  • 5.3. Manual thrombectomy devices
    • 5.3.1. Market size and forecast

CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Neurovascular thrombectomy devices
    • 6.2.1. Market size and forecast
  • 6.3. Peripheral thrombectomy devices
    • 6.3.1. Market size and forecast
  • 6.4. Coronary thrombectomy devices
    • 6.4.1. Market size and forecast

CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Reusable thrombectomy devices
    • 7.2.1. Market size and forecast
  • 7.3. Disposable thrombectomy devices
    • 7.3.1. Market size and forecast

CHAPTER 8: COMPANY PROFILES

  • 8.1. BOSTON SCIENTIFIC CORPORATION
    • 8.1.1. Company overview
    • 8.1.2. Company snapshot
    • 8.1.3. Operating business segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Business performance
    • 8.1.6. Key strategic moves and developments
  • 8.2. JOHNSON & JOHNSON
    • 8.2.1. Company overview
    • 8.2.2. Company snapshot
    • 8.2.3. Operating business segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business performance
    • 8.2.6. Key strategic moves and developments
  • 8.3. MEDTRONIC PLC
    • 8.3.1. Company overview
    • 8.3.2. Company snapshot
    • 8.3.3. Operating business segments
    • 8.3.4. Product portfolio
    • 8.3.5. Business performance
    • 8.3.6. Key strategic moves and developments
  • 8.4. Stryker Corporation
    • 8.4.1. Company overview
    • 8.4.2. Company snapshot
    • 8.4.3. Operating business segments
    • 8.4.4. Product portfolio
    • 8.4.5. Business performance
    • 8.4.6. Key strategic move and development
  • 8.5. Teleflex Incorporated
    • 8.5.1. Company overview
    • 8.5.2. Company snapshot
    • 8.5.3. Operating business segments
    • 8.5.4. Product portfolio
    • 8.5.5. Business performance
    • 8.5.6. Key strategic move and development
  • 8.6. TERUMO MEDICAL CORPORATION
    • 8.6.1. Company overview
    • 8.6.2. Company snapshot
    • 8.6.3. Operating business segments
    • 8.6.4. Product portfolio
    • 8.6.5. Business performance
    • 8.6.6. Key strategic move and development
  • 8.7. KONINKLIJKE PHILIPS N.V.
    • 8.7.1. Company overview
    • 8.7.2. Company snapshot
    • 8.7.3. Operating business segments
    • 8.7.4. Business performance
    • 8.7.5. Product portfolio
    • 8.7.6. Key strategic moves and developments
  • 8.8. Angiodynamics Inc.
    • 8.8.1. Company overview
    • 8.8.2. Company snapshot
    • 8.8.3. Operating business segments
    • 8.8.4. Product Portfolio
    • 8.8.5. Business performance
  • 8.9. Penumbra, Inc.
    • 8.9.1. Company overview
    • 8.9.2. Company snapshot
    • 8.9.3. Operating business segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business performance
    • 8.9.6. Key strategic moves and developments
  • 8.10. Capture Vascular, Inc.
    • 8.10.1. Company overview
    • 8.10.2. Company snapshot
    • 8.10.3. Operating business segments
    • 8.10.4. Product portfolio

List of Tables

  • TABLE 01. U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20172025 ($MILLION)
  • TABLE 02. U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 20172025 ($MILLION)
  • TABLE 03. U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 20172025 ($MILLION)
  • TABLE 04. U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 20172025 ($MILLION)
  • TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 08. J&J: COMPANY SNAPSHOT
  • TABLE 09. J&J: OPERATING SEGMENTS
  • TABLE 10. J&J: PRODUCT PORTFOLIO
  • TABLE 11. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 12. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 13. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 14. STRYKER: COMPANY SNAPSHOT
  • TABLE 15. STRYKER: OPERATING SEGMENTS
  • TABLE 16. STRYKER: PRODUCT PORTFOLIO
  • TABLE 17. TELEFLEX: COMPANY SNAPSHOT
  • TABLE 18. TELEFLEX: OPERATING SEGMENTS
  • TABLE 19. TELEFLEX: PRODUCT PORTFOLIO
  • TABLE 20. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 21. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 22. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 23. PHILIPS: COMPANY SNAPSHOT
  • TABLE 24. PHILIPS: OPERATING SEGMENTS
  • TABLE 25. PHILIPS: PRODUCT PORTFOLIO
  • TABLE 26. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
  • TABLE 27. ANGIODYNAMICS INC: OPERATING SEGMENTS
  • TABLE 28. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
  • TABLE 29. PENUMBRA, INC.: COMPANY SNAPSHOT
  • TABLE 30. PENUMBRA INC: OPERATING SEGMENTS
  • TABLE 31. PENUMBRA, INC.: PRODUCT PORTFOLIO
  • TABLE 32. CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
  • TABLE 33. CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
  • TABLE 34. CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO

List of Figures

  • FIGURE 01. U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
  • FIGURE 02. TOP WINNING STRATEGIES, 20152018
  • FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20152018
  • FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
  • FIGURE 05. TOP INVESTMENT POCKETS
  • FIGURE 06. TOP PLAYER POSITIONING, 2017
  • FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10. MODERATE THREAT OF SUBSTITUTION
  • FIGURE 11. HIGH COMPETITIVE RIVALRY
  • FIGURE 12. MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 13. U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 14. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 15. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 16. U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 20172025 ($MILLION)
  • FIGURE 17. U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 18. U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 19. U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 20. U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 21. U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 22. U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 20172025 ($MILLION)
  • FIGURE 23. BOSTON SCIENTIFIC: NET SALES, 20152017 ($MILLION)
  • FIGURE 24. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
  • FIGURE 25. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
  • FIGURE 26. J&J: NET SALES, 20152017 ($MILLION)
  • FIGURE 27. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
  • FIGURE 28. J&J: REVENUE SHARE, BY REGION, 2017 (%)
  • FIGURE 29. MEDTRONIC: NET SALES, 20152017 ($MILLION)
  • FIGURE 30. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
  • FIGURE 31. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
  • FIGURE 32. STRYKER: NET SALES, 20152017 ($MILLION)
  • FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 34. STRYKER: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 35. TELEFLEX: NET SALES, 20152017 ($MILLION)
  • FIGURE 36. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 37. TERUMO MEDICAL CORPORATION: NET SALES, 20152017 ($MILLION)
  • FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
  • FIGURE 39. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
  • FIGURE 40. PHILIPS: NET SALES, 20152017 ($MILLION)
  • FIGURE 41. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 42. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
  • FIGURE 43. ANGIODYNAMICS INC: REVENUE, 20162018 ($MILLION)
  • FIGURE 44. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 45. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 46. PENUMBRA, INC.: REVENUE, 20162018 ($MILLION)
  • FIGURE 47. PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 48. PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)
Back to Top